Stocks
Alnylam Pharmaceuticals (ALNY) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -868.1 | -736.3 | -661.6 | -926.6 | -258.2 | -130.9 | ||
| Changes by years, y/y, % | +4% | -15% | -10% | +40% | -72% | -20.9% | |||
Alnylam Pharmaceuticals. EBITDA US GAAP, bln rub
Alnylam Pharmaceuticals. EBITDA US GAAP, changes, %
Alnylam Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Alnylam Pharmaceuticals (ALNY) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 195.0 | -92.9 | -14.8 | 37.1 | -60.3 | -130.9 | |
| Changes by years, y/y, % | -183% | -48% | -90% | -115% | -131% | |||
| Changes by quarters, q/q, % | -180% | -148% | -84% | -350% | -263% | |||
